manzamine F: manzamine alkaloid with potent activity against infectious diseases; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6474225 |
| SCHEMBL ID | 11915474 |
| MeSH ID | M0400971 |
| Synonym |
|---|
| manzamine f |
| (+)-manzamine f |
| (4ar,7s,7ar,15ar)-7-hydroxy-5-(8-hydroxy-9h-beta-carbolin-1-yl)-4,4a,7,7a,10,11,13,14,14a,15-decahydro-3h-7,2-oct[3]enoazocino[1',2':1,5]pyrrolo[2,3-i]isoquinolin-12(9h)-one |
| hydroxy-(8-hydroxy-9h-pyrido[3,4-b]indol-1-yl)[?]one |
| SCHEMBL11915474 |
| (1r,2r,12r,13s,16z)-13-hydroxy-25-(8-hydroxy-9h-pyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-16,25-dien-7-one |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||